Jul 2 |
QIAGEN N.V. to release results for Q2 2024 and hold webcast
|
Jun 30 |
Street calls of the week: Stifel initiates on Tesla; downgrade for Alphabet
|
Jun 28 |
QIAGEN (QGEN) Backs New AAP Guidelines Supporting QFT-Plus Test
|
Jun 27 |
QIAGEN welcomes new U.S. guidelines for use of QuantiFERON-TB Gold Plus in detecting tuberculosis infections in children
|
Jun 27 |
Qiagen upgraded at Wolfe on valuation discount
|
Jun 24 |
FDA Approves Bristol Myers Squibb's Combination Therapy For Colorectal Cancer Patients With Certain Type Of Gene Mutation
|
Jun 20 |
Vanda Pharmaceuticals And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
|
Jun 19 |
QIAGEN's (QGEN) New QCI Interpret Release Enhances AI Functions
|
Jun 17 |
QIAGEN (QGEN) Debuts dPCR Microbial DNA Detection Assays
|
Jun 17 |
QIAGEN announces 2028 strategy for solid profitable growth
|